| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.669 | 25.015 | 35.443 | 37.250 | 39.960 | 44.868 | 58.648 | 66.550 |
| Total Income - EUR | - | - | 1.669 | 25.016 | 35.444 | 38.801 | 39.960 | 44.868 | 60.670 | 66.552 |
| Total Expenses - EUR | - | - | 1.294 | 17.930 | 19.558 | 24.095 | 26.128 | 31.357 | 37.986 | 38.167 |
| Gross Profit/Loss - EUR | - | - | 375 | 7.086 | 15.885 | 14.706 | 13.833 | 13.511 | 22.684 | 28.385 |
| Net Profit/Loss - EUR | - | - | 375 | 6.836 | 15.531 | 14.335 | 13.433 | 13.063 | 22.077 | 26.389 |
| Employees | - | - | 2 | 2 | 2 | 3 | 3 | 0 | 2 | 3 |
Check the financial reports for the company - Camirobimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 4.141 | 2.032 | 6.322 | 4.962 | 19.450 | 15.067 | 10.080 | 7.129 |
| Current Assets | - | - | 2.743 | 5.741 | 17.061 | 20.770 | 9.884 | 7.664 | 17.735 | 22.449 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 184 | 286 | 184 | 0 |
| Receivables | - | - | 1.669 | 2.487 | 3.480 | 3.585 | 5.166 | 3.661 | 8.712 | 209 |
| Cash | - | - | 1.074 | 3.254 | 13.581 | 17.185 | 4.534 | 3.717 | 8.839 | 22.240 |
| Shareholders Funds | - | - | 419 | 7.246 | 15.573 | 14.377 | 13.474 | 13.103 | 22.117 | 26.429 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 6.465 | 527 | 7.810 | 11.355 | 15.860 | 9.629 | 5.698 | 3.149 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Camirobimed Srl